Reid Austin Maclellan, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphedema | 14 | 2020 | 527 | 3.200 |
Why?
|
| Receptors, FSH | 2 | 2018 | 29 | 1.070 |
Why?
|
| Lipectomy | 3 | 2017 | 115 | 1.040 |
Why?
|
| Vascular Malformations | 5 | 2018 | 469 | 0.980 |
Why?
|
| Hemangioma, Capillary | 3 | 2018 | 64 | 0.740 |
Why?
|
| Lipomatosis | 2 | 2015 | 112 | 0.530 |
Why?
|
| Parietal Bone | 1 | 2016 | 49 | 0.520 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2018 | 726 | 0.520 |
Why?
|
| Dura Mater | 1 | 2016 | 297 | 0.450 |
Why?
|
| Vascular Neoplasms | 1 | 2014 | 167 | 0.400 |
Why?
|
| Bone Transplantation | 1 | 2016 | 925 | 0.370 |
Why?
|
| Menopause | 1 | 2018 | 1653 | 0.340 |
Why?
|
| Cicatrix | 1 | 2016 | 799 | 0.340 |
Why?
|
| Obesity | 3 | 2016 | 13084 | 0.330 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2015 | 2884 | 0.290 |
Why?
|
| Referral and Consultation | 2 | 2020 | 3627 | 0.270 |
Why?
|
| Mutation, Missense | 1 | 2014 | 2593 | 0.230 |
Why?
|
| Lower Extremity | 5 | 2019 | 1218 | 0.220 |
Why?
|
| Hemangioma | 3 | 2014 | 727 | 0.220 |
Why?
|
| Leg | 2 | 2019 | 1088 | 0.210 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15939 | 0.180 |
Why?
|
| Suction | 2 | 2016 | 268 | 0.150 |
Why?
|
| Abnormalities, Multiple | 2 | 2015 | 1424 | 0.150 |
Why?
|
| Lymphatic Vessels | 2 | 2020 | 356 | 0.150 |
Why?
|
| Hemangioendothelioma | 1 | 2017 | 112 | 0.140 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2016 | 45 | 0.140 |
Why?
|
| Lip | 1 | 2018 | 198 | 0.130 |
Why?
|
| Upper Extremity | 2 | 2019 | 684 | 0.130 |
Why?
|
| Oral Surgical Procedures | 1 | 2018 | 172 | 0.130 |
Why?
|
| Propranolol | 1 | 2017 | 493 | 0.130 |
Why?
|
| Frontal Bone | 1 | 2016 | 106 | 0.130 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2016 | 89 | 0.130 |
Why?
|
| Telangiectasis | 1 | 2015 | 78 | 0.120 |
Why?
|
| Pericytes | 1 | 2018 | 299 | 0.120 |
Why?
|
| Skin Diseases, Vascular | 1 | 2015 | 41 | 0.120 |
Why?
|
| Infant | 8 | 2018 | 36510 | 0.120 |
Why?
|
| Treatment Refusal | 1 | 2018 | 432 | 0.120 |
Why?
|
| Sarcoma, Kaposi | 1 | 2017 | 374 | 0.120 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 1 | 2015 | 69 | 0.120 |
Why?
|
| Female | 23 | 2020 | 397089 | 0.120 |
Why?
|
| Arm | 1 | 2017 | 590 | 0.120 |
Why?
|
| Diagnostic Errors | 3 | 2017 | 1280 | 0.120 |
Why?
|
| Appointments and Schedules | 1 | 2018 | 442 | 0.110 |
Why?
|
| Endothelial Cells | 2 | 2018 | 3587 | 0.110 |
Why?
|
| Granuloma, Pyogenic | 1 | 2014 | 47 | 0.110 |
Why?
|
| Male | 22 | 2020 | 364902 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 3 | 2018 | 6085 | 0.110 |
Why?
|
| Child, Preschool | 9 | 2017 | 42650 | 0.110 |
Why?
|
| Lymphatic Abnormalities | 1 | 2015 | 134 | 0.110 |
Why?
|
| Subcutaneous Tissue | 1 | 2014 | 131 | 0.110 |
Why?
|
| Child | 12 | 2020 | 80891 | 0.110 |
Why?
|
| Facies | 1 | 2014 | 224 | 0.110 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2015 | 249 | 0.100 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2015 | 906 | 0.100 |
Why?
|
| Capillaries | 1 | 2016 | 756 | 0.100 |
Why?
|
| Logistic Models | 2 | 2017 | 13323 | 0.100 |
Why?
|
| Middle Aged | 11 | 2019 | 223491 | 0.100 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2014 | 164 | 0.100 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2017 | 1244 | 0.100 |
Why?
|
| Humans | 28 | 2020 | 768393 | 0.100 |
Why?
|
| DNA | 2 | 2016 | 7211 | 0.090 |
Why?
|
| Hypercalcemia | 1 | 2014 | 423 | 0.090 |
Why?
|
| Craniotomy | 1 | 2016 | 747 | 0.090 |
Why?
|
| Arm Injuries | 1 | 2012 | 156 | 0.090 |
Why?
|
| Face | 2 | 2015 | 1031 | 0.090 |
Why?
|
| Leg Injuries | 1 | 2012 | 180 | 0.090 |
Why?
|
| Gene Library | 1 | 2014 | 1061 | 0.090 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2014 | 326 | 0.090 |
Why?
|
| Adult | 12 | 2020 | 223640 | 0.090 |
Why?
|
| Compartment Syndromes | 1 | 2012 | 159 | 0.090 |
Why?
|
| Skin Neoplasms | 3 | 2017 | 5857 | 0.090 |
Why?
|
| Specialization | 1 | 2015 | 781 | 0.090 |
Why?
|
| Cytodiagnosis | 1 | 2014 | 453 | 0.090 |
Why?
|
| Mosaicism | 1 | 2014 | 481 | 0.090 |
Why?
|
| Genetic Heterogeneity | 1 | 2014 | 737 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2015 | 2281 | 0.090 |
Why?
|
| Rabbits | 1 | 2016 | 4781 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2018 | 22296 | 0.080 |
Why?
|
| Age Distribution | 1 | 2015 | 2877 | 0.080 |
Why?
|
| Osteogenesis | 1 | 2016 | 1295 | 0.080 |
Why?
|
| Carcinoma, Papillary | 1 | 2014 | 793 | 0.080 |
Why?
|
| ROC Curve | 1 | 2016 | 3623 | 0.080 |
Why?
|
| Young Adult | 6 | 2019 | 60049 | 0.080 |
Why?
|
| Siblings | 1 | 2012 | 829 | 0.070 |
Why?
|
| Aged | 7 | 2019 | 171562 | 0.070 |
Why?
|
| Adolescent | 7 | 2018 | 89184 | 0.070 |
Why?
|
| Family Health | 1 | 2012 | 1255 | 0.070 |
Why?
|
| Skin Transplantation | 1 | 2012 | 1097 | 0.070 |
Why?
|
| Thyroid Nodule | 1 | 2014 | 767 | 0.070 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 12092 | 0.070 |
Why?
|
| Reoperation | 1 | 2016 | 4341 | 0.060 |
Why?
|
| Stem Cells | 1 | 2018 | 3539 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2014 | 26411 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 13020 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 4427 | 0.050 |
Why?
|
| Pediatrics | 1 | 2018 | 3624 | 0.050 |
Why?
|
| Age of Onset | 2 | 2019 | 3345 | 0.050 |
Why?
|
| Wound Healing | 1 | 2012 | 2813 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 59686 | 0.050 |
Why?
|
| Phenotype | 1 | 2019 | 16721 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 2014 | 2360 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2016 | 39407 | 0.040 |
Why?
|
| Radioactive Tracers | 1 | 2019 | 68 | 0.040 |
Why?
|
| Lymphatic System | 1 | 2020 | 252 | 0.040 |
Why?
|
| Head and Neck Neoplasms | 1 | 2012 | 2923 | 0.040 |
Why?
|
| Retrospective Studies | 6 | 2018 | 81801 | 0.040 |
Why?
|
| Prognosis | 2 | 2015 | 30022 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2015 | 13052 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2015 | 24318 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2017 | 65379 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2015 | 41795 | 0.030 |
Why?
|
| Inappropriate Prescribing | 1 | 2017 | 213 | 0.030 |
Why?
|
| Tennessee | 1 | 2014 | 123 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2014 | 7955 | 0.030 |
Why?
|
| Organ Size | 1 | 2019 | 2268 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2015 | 562 | 0.030 |
Why?
|
| Mutation | 2 | 2016 | 30228 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2014 | 575 | 0.030 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2012 | 47 | 0.030 |
Why?
|
| Risk Factors | 2 | 2016 | 74962 | 0.020 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2012 | 156 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 23631 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 21162 | 0.020 |
Why?
|
| Extremities | 1 | 2015 | 870 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 1974 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2014 | 1132 | 0.020 |
Why?
|
| Injury Severity Score | 1 | 2012 | 1046 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 2014 | 914 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2017 | 2168 | 0.020 |
Why?
|
| Suture Techniques | 1 | 2012 | 777 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4120 | 0.020 |
Why?
|
| United States | 1 | 2015 | 73150 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 36849 | 0.020 |
Why?
|
| Laser Therapy | 1 | 2012 | 1105 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5900 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 6892 | 0.010 |
Why?
|
| Comorbidity | 1 | 2019 | 10588 | 0.010 |
Why?
|
| Animals | 1 | 2016 | 169337 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2012 | 1890 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3666 | 0.010 |
Why?
|
| Survival Rate | 1 | 2014 | 12870 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 11254 | 0.010 |
Why?
|
| Length of Stay | 1 | 2012 | 6519 | 0.010 |
Why?
|
| Prevalence | 1 | 2014 | 15872 | 0.010 |
Why?
|
| Quality of Life | 1 | 2015 | 13503 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 40272 | 0.010 |
Why?
|